Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Tigris Series A Gets $11.6M For Topical Product In HPV

Oct. 17, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Praecis Continues Cost-Cutting Efforts, Sells Research Facility

Oct. 12, 2005

By Jennifer Boggs

CepTor Adding $20M To Test Myodur In Muscular Dystrophy

Oct. 12, 2005

By Jennifer Boggs

CepTor Adding $20M To Test Myodur In Muscular Dystrophy

Oct. 12, 2005

By Jennifer Boggs

Praecis Continues Cost-Cutting Efforts, Sells Research Facility

Oct. 12, 2005

By Jennifer Boggs

Vasogen Adds $40M Through Notes Sale For Celacade Work

Oct. 11, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...